---

This study was conducted because we were concerned about the absence of data on PTIF even though it at least partly determines the effectiveness of the first-line treatment most often chosen for AVB management, ie, high-flow nasal cannula oxygen therapy (HFNC). Indeed, measurements have been recorded in very preterm or healthy full-term neonates, but none in patients with AVB.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Letters to the Editor Source Type: research